Prostate cancer is the second most common cancer in US men, after skin cancer, as roughly 1 in 8 men will be diagnosed in their lifetime.
In an Untitled Letter, regulators said Facebook promotions for Pfizer’s lymphoma therapy overstated its approved use and ...
The FDA’s Office of Prescription Drug Promotion has issued a warning letter to drugmaker ImmunityBio over misleading promotional materials for Anktiva, a bladder cancer drug. The March 13 letter cited ...
Federal health regulators have formally warned ImmunityBio Inc. for making misleading promotional claims about Anktiva, the ...